Skip to main content
. 2023 Apr 25;9(2):e003029. doi: 10.1136/rmdopen-2023-003029

Figure 1.

Figure 1

Sankey diagram describing proportion of patients per CDAI disease activity category over time. (A) Tofacitinib discontinuation arm (n=56), (B) methotrexate discontinuation arm (n=57). Data are n (%). CDAI, Clinical Disease Activity Index.